20.01.2015 Views

View - ResearchGate

View - ResearchGate

View - ResearchGate

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

220 Charlton<br />

3.3. Cleavage of Fusion Proteins with Cysteine Proteases<br />

1. If the fusion protein sample contains urea or guanidine (see Note 5), ionic<br />

detergents >0.01% (see Note 6), Zn ++ >5 mM (see Note 23) or known protease<br />

inhibitors (see Note 8), dialyze into cleavage buffer.<br />

2. Concentrate or dilute the fusion protein preparation to approximately 0.5 mg/ml<br />

(see Note 9).<br />

3. Dilute the protease preparation to 0.05 units/μl (or 0.05 μg/μl) in cleavage<br />

buffer (see Note 10). Keep protease preparations and stock on ice until<br />

needed.<br />

4. Set up a pilot cleavage by mixing 100 μl of fusion protein (50 μg at 0.5 μg/μl,<br />

see step 2) with 10 μl of protease dilution (see step 3). Prepare a negative control<br />

reaction by adding 2 μl of cleavage buffer to 20 μl of fusion protein preparation.<br />

Incubate these reactions at 4°C (see Note 24). If a positive cleavage control was<br />

supplied, prepare this reaction according to the manufacturer’s directions.<br />

5. Terminate the reactions after 24 h by adding 22 μl of 2× reducing SDS-PAGE<br />

loading buffer (see Notes 12 and 13). Store at –20°C until the samples are ready<br />

to run on SDS-PAGE (see Note 14).<br />

6. Analyze the time point samples and the control(s) on SDS-PAGE.<br />

7. If there is significant degradation of the target protein (see Note 25) go to step 8.<br />

If there is incomplete cleavage (see Note 16), or no cleavage apparent where a<br />

positive control was successful, go to step 10. If the cleavage was successful, go<br />

to step 12.<br />

8. Carefully analyze the negative (no protease) control (see Note 26); if degradation<br />

is observed in this reaction, consider expression in a host protease-deficient<br />

bacterial strain such as Escherichia coli BL21(DE3). The inclusion of protease<br />

inhibitors that do not affect cysteine proteases may also be beneficial, see<br />

Table 3. Return to step 4 with inhibitor inclusions or new host strain. Where<br />

the degradation is observed to be attributable to the viral protease, continue to<br />

step 9.<br />

9. Incubation with a lower amount of protease may help to minimize (see Note 17)<br />

internal cleavage of the target protein. Dilute the protease preparation to 0.005<br />

and 0.0005 units/μl (or 5 and 0.5 ng/μl). To 2 × 20 μl of fusion protein from step<br />

2, add 2 μl each of these protease dilutions. Incubate at 4°C for 24 h. Terminate<br />

the reaction (see Note 13) and analyze by SDS-PAGE. If these reactions yield<br />

sufficient correctly cleaved target protein, go to step 12. Otherwise continue to<br />

step 11.<br />

10. Increasing the concentration of protease may enable cleavage. Dilute the protease<br />

preparation to 0.25 and 0.5 units/μl (or μg/μl). Add 4 μl of each protease dilution to<br />

40 μl of fusion protein from step 2. To another 40 μl of fusion protein, add 4 μl of<br />

neat protease stock. Incubate the reactions at 4°C for 24 h. Terminate the reactions<br />

(see Note 13) and analyze by SDS-PAGE. If these reactions yield sufficient<br />

correctly cleaved target protein, go to step 12. If these protease concentrations<br />

remain unable to produce adequate levels of correctly cleaved material, go to<br />

step 11.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!